Sepsis Diagnostic Market by Testing Type, Technology, Product, Method, Pathogen, End-user - Global Forecast 2025-2030- Product Image

Sale

Sepsis Diagnostic Market by Testing Type, Technology, Product, Method, Pathogen, End-user - Global Forecast 2025-2030

Report
195 Pages
October 2024
Region: Global
360iResearch™
ID: 5311190

UP TO €684EUR$697USD£571GBP OFF until Dec 31^st 2024

The Sepsis Diagnostic Market grew from USD 556.86 million in 2023 to USD 611.80 million in 2024. It is expected to continue growing at a CAGR of 9.98%, reaching USD 1.08 billion by 2030.

The sepsis diagnostic market is an essential segment within the healthcare industry, focusing on identifying sepsis, a severe systemic response to infection. The scope of this market encompasses a range of diagnostic tools, including microbiological assays, immunoassays, molecular diagnostics, and biomarkers, aimed at early and accurate detection to improve patient outcomes. Applications of sepsis diagnostics are pivotal in emergency departments, intensive care units, and diagnostic laboratories, primarily serving hospitals and clinics to reduce morbidity and mortality rates. The necessity for advanced sepsis diagnostics is driven by the increasing prevalence of sepsis, heightened awareness amongst healthcare professionals, and the urgent need to reduce healthcare costs associated with hospital stays and complex treatments due to late diagnosis.

Key factors influencing market growth include growing investments in healthcare infrastructure, rapid advancements in diagnostic technologies, and favorable governmental initiatives supporting research and development for efficient diagnostic solutions. Furthermore, the rising demand for rapid diagnostic methods due to their potential for early intervention presents significant opportunities. Companies can harness advancements in AI and machine learning for predictive analytics in sepsis prognosis, exploiting big data for tailored diagnostic solutions. However, market limitations include high costs associated with advanced diagnostic tools, lack of awareness in developing regions, and variability in sepsis presentation complicating diagnostic standardization.

To capitalize on growth opportunities, businesses should focus on innovations like point-of-care diagnostic tests that provide quick results and integration with digital health technologies for real-time monitoring. Collaboration with hospitals and healthcare institutions to build awareness and offer training programs would enhance market penetration. Despite the promising potential, the market faces challenges such as stringent regulatory pathways and the need for high accuracy in diagnostic products to avoid false negatives or positives. Thus, continuous investment in research and inter-disciplinary collaborations emerge as crucial strategies to fortify market position and foster robust developments in sepsis diagnostics.

Understanding Market Dynamics in the Sepsis Diagnostic Market

The Sepsis Diagnostic Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing Incidence and Prevalence of Sepsis
- Growing Occurrence of Hospital Derived Infections
- Development of Technology Advanced Diagnostic Solutions
Market Restraints
- Capital Intensive Automated Diagnostic Services and Dearth of Reimbursement Situations
Market Opportunities
- Emerging Development of Rapid Diagnostics Globally
- Development of Novel Biomarkers for Sepsis Diagnostics
Market Challenges
- Lack of Awareness and Standard Protocols for the Procedure

Exploring Porter’s Five Forces for the Sepsis Diagnostic Market

Porter’s Five Forces framework further strengthens the insights of the Sepsis Diagnostic Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Sepsis Diagnostic Market

External macro-environmental factors deeply influence the performance of the Sepsis Diagnostic Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Sepsis Diagnostic Market

The Sepsis Diagnostic Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Sepsis Diagnostic Market

The Sepsis Diagnostic Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Sepsis Diagnostic Market

The Sepsis Diagnostic Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sepsis Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alifax S.r.l., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Boditech Med Inc., Bruker Corporation, CytoSorbents Corporation, DiaSorin S.p.A., EKF Diagnostics, F. Hoffmann-La Roche AG, Immunexpress Inc., Koninklijke Philips N.V., McKesson Corporation, Merck KGaA, Molzym GmbH & Co. KG, Nanomix Inc., Oracle Corporation, QIAGEN N.V., Response Biomedical Corporation, Seegene Inc., Siemens Healthineers, T2 Biosystems, Thermo Fisher Scientific, Inc., and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Sepsis Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Testing Type
- Laboratory Testing
- PoC Testing
Technology
- Flow Cytometry
- Immunoassays
- Microbiology
- Molecular Diagnostics
Product
- Assay Kits and Reagents
- Blood Culture Media
- Instruments
- Software
Method
- Automated Diagnostics
- Conventional Diagnostics
Pathogen
- Bacterial Sepsis
  - Gram-Negative Bacteria
  - Gram-Positive Bacteria
- Fungal Sepsis
End-user
- Hospitals
- Pathology & Reference Laboratories
- Research Laboratories & Academic Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence and Prevalence of Sepsis
5.1.1.2. Growing Occurrence of Hospital Derived Infections
5.1.1.3. Development of Technology Advanced Diagnostic Solutions
5.1.2. Restraints
5.1.2.1. Capital Intensive Automated Diagnostic Services and Dearth of Reimbursement Situations
5.1.3. Opportunities
5.1.3.1. Emerging Development of Rapid Diagnostics Globally
5.1.3.2. Development of Novel Biomarkers for Sepsis Diagnostics
5.1.4. Challenges
5.1.4.1. Lack of Awareness and Standard Protocols for the Procedure
5.2. Market Segmentation Analysis
5.2.1. Testing Type: Increasing usage of PoC testing solutions for sepsis diagnostics
5.2.2. End-user: Emerging use of advanced sepsis diagnostics solutions in pathology and reference laboratories
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Sepsis Diagnostic Market, by Testing Type

6.1. Introduction
6.2. Laboratory Testing
6.3. PoC Testing

7. Sepsis Diagnostic Market, by Technology

7.1. Introduction
7.2. Flow Cytometry
7.3. Immunoassays
7.4. Microbiology
7.5. Molecular Diagnostics

8. Sepsis Diagnostic Market, by Product

8.1. Introduction
8.2. Assay Kits and Reagents
8.3. Blood Culture Media
8.4. Instruments
8.5. Software

9. Sepsis Diagnostic Market, by Method

9.1. Introduction
9.2. Automated Diagnostics
9.3. Conventional Diagnostics

10. Sepsis Diagnostic Market, by Pathogen

10.1. Introduction
10.2. Bacterial Sepsis
10.3. Fungal Sepsis

11. Sepsis Diagnostic Market, by End-user

11.1. Introduction
11.2. Hospitals
11.3. Pathology & Reference Laboratories
11.4. Research Laboratories & Academic Institutes

12. Americas Sepsis Diagnostic Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Sepsis Diagnostic Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Sepsis Diagnostic Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Unveiling of FDA-Authorized AI Tool by Prenosis, Inc.
15.3.2. Innovative AI-Powered Early Detection of Sepsis by Presymptom Health Secures GBP 1.5 Million in Funding
15.3.3. Cytovale's Strategic Advancement with USD 84 Million Series C Funding
15.4. Strategy Analysis & Recommendation

16. Competitive Portfolio

16.1. Key Company Profiles
16.2. Key Product Portfolio

List of Figures

FIGURE 1. SEPSIS DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. SEPSIS DIAGNOSTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SEPSIS DIAGNOSTIC MARKET DYNAMICS
FIGURE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2023 VS 2030 (%)
FIGURE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. SEPSIS DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 28. SEPSIS DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. SEPSIS DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ASSAY KITS AND REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ASSAY KITS AND REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AUTOMATED DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AUTOMATED DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-POSITIVE BACTERIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-POSITIVE BACTERIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FUNGAL SEPSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FUNGAL SEPSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 104. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 105. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 106. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 107. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 110. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 111. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 112. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 113. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 114. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 115. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 118. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 119. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 120. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 121. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 122. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 123. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 124. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 125. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 126. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 127. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 128. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 129. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 133. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 134. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 135. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 148. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 163. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 164. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 165. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 166. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 167. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 170. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 178. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 179. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 184. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 185. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 186. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 187. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 188. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 189. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 192. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 193. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 198. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 199. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 200. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 201. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 202. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 203. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 206. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 207. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 208. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 209. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 210. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 211. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 212. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 220. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 221. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 226. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 227. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 228. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 229. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 230. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 231. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 234. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 235. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 240. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 243. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 244. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 245. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 248. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 249. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 250. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 251. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 254. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 257. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 258. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 259. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 262. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 263. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 264. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 265. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 268. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 271. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 272. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 273. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 276. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 277. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 278. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 279. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 280. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 281. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 282. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 285. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 286. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 287. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 290. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 291. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 292. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 293. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 296. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 299. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 300. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 301. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 302. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 303. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 304. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 305. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 306. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 307. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 308. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 309. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 310. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 311. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 312. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 313. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 314. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 315. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 316. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 317. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 318. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 319. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 320. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 321. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 322. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 323. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 324. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 325. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 326. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 327. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 328. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 329. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 330. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 347. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 348. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 349. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 350. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 351. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 352. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 353. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 354. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 355. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 356. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 357. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 358. DENMARK SEPSIS DIAGNOS

Companies Mentioned

The leading players in the Sepsis Diagnostic market, which are profiled in this report, include:

Abbott Laboratories
Alifax S.r.l.
Beckman Coulter, Inc.
Becton, Dickinson and Company
bioMérieux SA
Boditech Med Inc.
Bruker Corporation
CytoSorbents Corporation
DiaSorin S.p.A.
EKF Diagnostics
F. Hoffmann-La Roche AG
Immunexpress Inc.
Koninklijke Philips N.V.
McKesson Corporation
Merck KGaA
Molzym GmbH & Co. KG
Nanomix Inc.
Oracle Corporation
QIAGEN N.V.
Response Biomedical Corporation
Seegene Inc.
Siemens Healthineers
T2 Biosystems
Thermo Fisher Scientific, Inc.
Wolters Kluwer N.V.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 611.8 Million
Forecasted Market Value ( USD ) by 2030	$ 1080 Million
Compound Annual Growth Rate	9.9%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3481EUR$3,545USD£2,904GBP €3868EUR$3,939USD£3,227GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6158EUR$6,272USD£5,138GBP €6843EUR$6,969USD£5,709GBP

Understanding Market Dynamics in the Sepsis Diagnostic Market

Exploring Porter’s Five Forces for the Sepsis Diagnostic Market

Applying PESTLE Analysis to the Sepsis Diagnostic Market

Analyzing Market Share in the Sepsis Diagnostic Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Sepsis Diagnostic Market

Strategic Recommendations for Success in the Sepsis Diagnostic Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Sepsis Diagnostics Market Size, Share & Trends Analysis Report by Product (Assay Kits & Reagents, Blood Culture Media), Technology, Pathogen, Testing Type, Method, End-user, Region, and Segment Forecasts, 2024-2030

Sepsis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

Sepsis Diagnostics Market Size By Technology (Microbiology, PCR, Immunoassay, microfluidics, Biomarker), Product (Media, Reagent, Instrument), Method (Automated), Test (Lab, POC), Pathogen (Bacterial, Fungal), End User & Region - Forecast to 2029

Sepsis Diagnostics Market: Analysis By Technology, Product, Method, Pathogen Type, Test Type, End-User, Region Size, Trends and Forecast up to 2029

Sepsis Diagnostics - Global Strategic Business Report